Skip to main content

Virtual Registration

  1. Home
  2. Virtual Registration

Register for Virtual

Join the Live Broadcast—Wherever You Are

Be part of a vital discussion on the management of HER2+ metastatic breast cancer through this broadcasted event. This live-streamed event from London brings together leading experts, offering attendees valuable insights into current best practices in treatment and care.

Interact in Real Time: Virtual attendees will have the opportunity to submit questions to the panel during live Q&A sessions, making this an interactive experience tailored for meaningful discussion.

Don’t miss the chance to engage with leading voices in HER2+ metastatic breast cancer management.

To watch and participate on the day of the broadcast, simply register below.

 

View Agenda

 

 

REGISTER HERE


WORK ADDRESS


CONTACT INFORMATION


*I wish to register my place at this meeting and accept the information on Data Privacy. As a result of my registration, I understand I might receive promotional emails about this event, including joining instructions or reminder emails.


I hereby consent to receive email(s) from Daiichi Sankyo and AstraZeneca. These emails may contain non-promotional and/or promotional content.


By opting in to Daiichi Sankyo and AstraZeneca's mailing list you will receive both promotional and/or non-promotional emails from both companies, including invitations to webinars and meetings.

Please note that each company must verify your contact details against its own Healthcare Professional contact information database and if your contact details are already available within the AstraZeneca database a representative from AstraZeneca will email you to confirm your opt-in status. Alternately, if your details are already available within Daiichi Sankyo database a representative from Daiichi Sankyo will send you an email.

In the scenario of your contact details not being available within either company's respective database, a Daiichi Sankyo and/or AstraZeneca representative will contact you to advise how you can be added to the database and confirm your opt-in status.

If you have elected to receive information about any of Daiichi Sankyo or AstraZeneca's productions or services and wish to opt-out of receiving such information you can do so by sending an email to the respective company. For AstraZeneca email privacyrequests@astrazeneca.com and for Daiichi Sankyo email Data-Protection@daiichi-sankyo.eu. There is also an unsubscribe link at the bottom of our mailings that can be clicked if you wish to opt-out.

Please note that registration does not automatically guarantee a place at this meeting. An email confirmation will be sent upon successful registration.


 


Submit



Your email address and personal information will be used to communicate electronically with you about this meeting. If you do not wish to receive any communication, then please email us at Her2registration@HCPMED.NET.